SKIN

#3959
SkinHealth Systems Inc. - Class A Common Stock
0.7 1 USD
+0.04%
Market Price
Sektor: Konjunkturunabhängige Konsumgüter
Basis: USD
Gewinnwährung: USD
Tagesspanne
0.71
0.71
Jahresspanne
0.55
2.69
Tagesänderung
+4.41%
Monatliche Änderung
-1.39%
6 month change
-34.86%
Jahresänderung
-64.85%
Vorheriger Schlusskurs
0.6 8
Open
0.7 1
Tief
0.7 1
Hoch
0.7 1
Volumen
13
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
Skinhealth Systems Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Skinhealth Systems Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Skinhealth Systems Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Skinhealth Systems Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Skinhealth Systems Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Skinhealth Systems Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Skinhealth Systems Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Skinhealth Systems Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Skinhealth Systems Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Skinhealth Systems Inc. quarterly report, Q1 FY2026
10-Q

Skinhealth Systems Inc. current report, Q2 FY2026

Full document

Business Context and Reporting Period

Company: SkinHealth Systems Inc. (SKIN)
Filing Type: Form 8-K (Current Report)
Date of Report: May 7, 2026
Reporting Period: Fiscal quarter ended March 31, 2026
Context: The Company issued a press release and held a conference call to announce financial results for the quarter ended March 31, 2026. The filing references non-GAAP financial information with a reconciliation provided in the attached press release (Exhibit 99.1).

Key Financial Metrics

The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain specific numerical data. Consequently, the following metrics are not available in the source text:

  • Revenue: Not provided in filing text.
  • Profit/Loss: Not provided in filing text.
  • Cash Flow: Not provided in filing text.
  • Margins: Not provided in filing text.
  • Debt and Liquidity: Not provided in filing text.

Material Changes

The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.

Guidance, Outlook, and Risks

  • Management Commentary: The Company announced results via press release and conference call. Non-GAAP measures were utilized.
  • Disclosure Policy: The Company states it discloses material non-public information through SEC filings, press releases, conference calls, and its investor relations website.
  • Legal Disclaimer: Information furnished under Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
  • Guidance/Risks: No specific forward-looking guidance or risk factors are detailed in the 8-K text itself.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release) for actual revenue, earnings, and cash flow figures for the quarter ended March 31, 2026.
  • Examine the GAAP to non-GAAP reconciliation included in the press release to understand adjustments made to financial results.
  • Verify any forward-looking statements or guidance provided during the conference call referenced in the filing.
  • Check the Investor Relations website for additional materials or updates consistent with Regulation FD disclosures.

Nachrichten